NHC Q3 Income Declines
NHC reported Q3 2026 net income of $13.64M ($0.85/share), down from $39.24M ($2.50/share) in Q3 2025. Adjusted net income rose to $28.15M ($1.76/share). Revenues increased to $407.97M, while costs rose to $367.34M. Shares traded down 1.57% at $204.36.
How this was made
The 30-second read
Why it matters
The earnings miss could trigger short-term sell pressure, though revenue growth may mitigate longer-term concerns.
Market read
Earnings release provides fresh data for traders; potential short-term downside for NHC and related healthcare stocks.
What to watch
Revenue growth of $408 M vs $383 M suggests operational expansion despite profit decline.
Background
National HealthCare Corp (NHC) reported Q3 2026 results with lower net income but higher adjusted earnings and revenue growth.
Ticker impact
Q3 2026 earnings released showing net income fell 65% YoY and shares down 1.6% on NYSE.
likely downward pressure as market prices in the income decline.
The drop in net income to $13.64 M from $39.24 M is a material negative surprise; adjusted earnings improved but not enough to offset the headline miss.
Market effects
Healthcare services sector may see modest pullback as earnings miss signals broader margin pressure.
US healthcare stocks could face slight downside in early trading.
Limited; primarily affects US-listed healthcare providers.
Counterpoint
Adjusted earnings beat may support a bounce if investors focus on top‑line growth.
Key entities
- companyNational HealthCare Corporation
US-listed healthcare services provider (NYSE: NHC).
